Methylation status of Reprimo in head and neck carcinomas [2]

International Journal of Cancer

Volumn 117, Issue 4, 2005, Pages 697-

  Wong, Thian Sze ^a   Kwong, Dora Lai Wen ^a   Sham, Jonathan Shun Tong ^a   Wei, William Ignace ^a   Yuen, Anthony Po Wing ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE G2 PHASE; CONTROLLED STUDY; DIAGNOSTIC KIT; DNA METHYLATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LETTER; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REPRIMO GENE; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; GLYCOPROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; METHYLATION;

EID: 27144537909     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21208     Document Type: Letter

References (2)

1. Takahashi T, Suzuki M, Shigematsu H, Shivapurkar N, Echebiri C, Nomura M, Stastny V, Augustus M, Wu CW, Wistuba II, Meltzer SJ, Gazdar AF. Aberrant methylation of Reprimo in human malignancies. Int J Cancer 2005;115:503-510.
2. Suzuki M, Shigematsu H, Takahashi T, Shivapurkar N, Sathyanarayana UG, Iizasa T, Fujisawa T, Gazdar AF. Aberrant methylation of Reprimo in lung cancer. Lung Cancer 2005;47:309-314.